Abstract:Background: Heart failure, which is a major global health problem, is often preceded by pathological cardiac hypertrophy. The expansion of the cardiac vasculature, to maintain adequate supply of oxygen and nutrients, is a key determinant of whether the heart grows in a physiological compensated manner or a pathological decompensated manner. Bidirectional endothelial cell (EC)-cardiomyocyte (CMC) cross talk via cardiokine and angiocrine signaling plays an essential role in the regulation of cardiac growth and homeostasis. Currently, the mechanisms involved in the EC-CMC interaction are not fully understood, and very little is known about the EC-derived signals involved. Understanding how an excess of angiogenesis induces cardiac hypertrophy and how ECs regulate CMC homeostasis could provide novel therapeutic targets for heart failure. Methods: Genetic mouse models were used to delete vascular endothelial growth factor (VEGF) receptors, adeno-associated viral vectors to transduce the myocardium, and pharmacological inhibitors to block VEGF and ErbB signaling in vivo. Cell culture experiments were used for mechanistic studies, and quantitative polymerase chain reaction, microarrays, ELISA, and immunohistochemistry were used to analyze the cardiac phenotypes. Results: Both EC deletion of VEGF receptor (VEGFR)-1 and adeno-associated viral vector-mediated delivery of the VEGFR1-specific ligands VEGF-B or placental growth factor into the myocardium increased the coronary vasculature and induced CMC hypertrophy in adult mice. The resulting cardiac hypertrophy was physiological, as indicated by preserved cardiac function and exercise capacity and lack of pathological gene activation. These changes were mediated by increased VEGF signaling via endothelial VEGFR2, because the effects of VEGF-B and placental growth factor on both angiogenesis and CMC growth were fully inhibited by treatment with antibodies blocking VEGFR2 or by endothelial deletion of VEGFR2. To identify activated pathways downstream of VEGFR2, whole-genome transcriptomics and secretome analyses were performed, and the Notch and ErbB pathways were shown to be involved in transducing signals for EC-CMC cross talk in response to angiogenesis. Pharmacological or genetic blocking of ErbB signaling also inhibited part of the VEGF-B-induced effects in the heart. Conclusions: This study reveals that cross talk between the EC VEGFR2 and CMC ErbB signaling pathways coordinates CMC hypertrophy with angiogenesis, contributing to physiological cardiac growth.

Endothelial cell-cardiomyocyte cross-talk: understanding bidirectional paracrine signaling in cardiovascular homeostasis and disease

Paracrine Endocrinology of Cardiac Telocytes in Culture

Biomechanical Signaling Within the Developing Zebrafish Heart Attunes Endocardial Growth to Myocardial Chamber Dimensions

MicroRNAs As Potential Novel Therapeutic Targets and Tools for Regulating Paracrine Function of Endothelial Progenitor Cells

Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling

Endothelium-driven myocardial growth or nitric oxide at the crossroads

The role of endothelial cell in cardiac hypertrophy: Focusing on angiogenesis and intercellular crosstalk

The role of endothelial cell–pericyte interactions in vascularization and diseases

Cardiomyocyte crosstalk with endothelium modulates cardiac structure, function, and ischemia-reperfusion injury susceptibility through erythropoietin

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure

Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy.

It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease

The role of cardiac microenvironment in cardiovascular diseases: implications for therapy

Cellular Crosstalk between Endothelial and Smooth Muscle Cells in Vascular Wall Remodeling

If these myocytes could talk, they would speak the language of metabolites

Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer’s Disease

A coalition to heal—the impact of the cardiac microenvironment

Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway

Cell-cell interactions in the heart: advanced cardiac models and omics technologies

Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology

Cardiac-to-adipose axis in metabolic homeostasis and diseases: special instructions from the heart